SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-018648
Filing Date
2024-05-10
Accepted
2024-05-10 16:16:05
Documents
51
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 537565
2 ex31-1.htm EX-31.1 12570
3 ex31-2.htm EX-31.2 12831
4 ex32-1.htm EX-32.1 11632
5 form10-q_001.jpg GRAPHIC 28583
  Complete submission text file 0001493152-24-018648.txt   3443039

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pcsa-20240331.xsd EX-101.SCH 31625
7 XBRL CALCULATION FILE pcsa-20240331_cal.xml EX-101.CAL 36486
8 XBRL DEFINITION FILE pcsa-20240331_def.xml EX-101.DEF 125436
9 XBRL LABEL FILE pcsa-20240331_lab.xml EX-101.LAB 303640
10 XBRL PRESENTATION FILE pcsa-20240331_pre.xml EX-101.PRE 231116
54 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 333791
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39531 | Film No.: 24935100
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)